Table 4.
Demographical, laboratory, and treatment features of type 1 (T1D), type 2 (T2D) and gestational (GDM) diabetic patients
| Subjects | Age (years) | Gender | Insulin regular/NPH | Duration of diabetes (years) | Blood glucose (mg/dL) | Glycated hemoglobin (%) | Metformin (mg/day) | Duration of pregnancy (weeks) |
|---|---|---|---|---|---|---|---|---|
| T1DM-02 |
23 |
M |
Yes |
13 |
197 |
8.3 |
- |
- |
| T1DM-03 |
24 |
M |
Yes |
6 |
260 |
10 |
- |
- |
| T1DM-04 |
18 |
M |
Yes |
8 |
23 |
7.2 |
- |
- |
| T1DM-05 |
23 |
M |
Yes |
20 |
178 |
10.1 |
- |
- |
| T1DM-06 |
21 |
F |
Yes |
8 |
223 |
7.8 |
- |
- |
| T1DM-12 |
27 |
F |
Yes |
10 |
257 |
10.4 |
- |
- |
| T1DM-15 |
22 |
F |
Yes |
13 |
143 |
8.3 |
- |
- |
| Mean ± SD |
22.57 ± 2.76 |
|
|
11.14 ± 4.70 |
183 ± 82.08 |
8.87 ± 1.27 |
|
|
| T2DM-04 |
49 |
M |
No |
8 |
130 |
7.5 |
2550 |
- |
| T2DM-05 |
42 |
M |
Yes |
11 |
53 |
5.1 |
1700 |
- |
| T2DM-09 |
52 |
M |
No |
10 |
100 |
6.6 |
1700 |
- |
| T2DM-11 |
41 |
F |
Yes |
3 |
92 |
10.2 |
2550 |
- |
| T2DM-12 |
43 |
F |
No |
4 |
173 |
10.7 |
2550 |
- |
| T2DM-13 |
60 |
F |
Yes |
20 |
306 |
10.9 |
0 |
- |
| T2DM-16 |
56 |
F |
Yes |
20 |
295 |
12 |
2550 |
- |
| T2DM-17 |
61 |
F |
Yes |
20 |
101 |
7.8 |
2550 |
- |
| Mean ± SD |
50.5 ± 8.05 |
|
|
12 ± 7.15 |
156.25 ± 95.35 |
8.85 ± 2.43 |
|
|
| GDM-09 |
33 |
F |
No |
|
80 |
5 |
- |
35 |
| GDM-10 |
29 |
F |
Yes |
|
89 |
5.8 |
- |
37 |
| GDM-12 |
39 |
F |
No |
|
72 |
5.7 |
- |
32 |
| GDM-13 |
29 |
F |
Yes |
|
92 |
5.2 |
- |
28 |
| GDM-14 |
30 |
F |
No |
|
82 |
5 |
- |
34 |
| GDM-16 |
38 |
F |
Yes |
|
59 |
9.1 |
- |
34 |
| Mean ± SD | 33 ± 4.51 | 79 ± 12.06 | 5.96 ± 1.57 | 33.33 ± 3.07 |